FEB 13, 2020 7:40 PM PST

Study of Early-Onset Parkinson's Reveals Potential Therapeutic

WRITTEN BY: Carmen Leitch

Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising. Symptoms include tremors, rigid muscles, slow movement, and loss of balance, which all get worse over time. The neurodegenerative disorder happens when neurons in the brain that make a signaling molecule called dopamine start malfunctioning or dying. The reason for that neuronal dysfunction and death is still unknown.

Image credit: Pixabay

New research reported in Nature Medicine has focused on the ten percent of Parkinson's patients that are diagnosed from the ages of 21 to 50, which is younger than typical patients, who tend to be diagnosed when they are over 60.

"Young-onset Parkinson's is especially heartbreaking because it strikes people at the prime of life," said study co-author Michele Tagliati, MD, director of the Movement Disorders Program, vice-chair, and professor in the Department of Neurology at Cedars-Sinai. "This exciting new research provides hope that one day we may be able to detect and take early action to prevent this disease in at-risk individuals."

The researchers applied the Nobel-prize winning technique for generating stem cells from adult blood cells for this work. They obtained the cells from the early-onset Parkinson's patients, then used the patient-derived induced pluripotent stem cells they created to make neurons that produce dopamine. They were then able to study these patient-derived cells in the lab to assess their physiology.

"Our technique gave us a window back in time to see how well the dopamine neurons might have functioned from the very start of a patient's life," noted the senior author of the study Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute and a professor of Biomedical Sciences and Medicine at Cedars-Sinai.

Two critical cellular abnormalities were identified by the scientists; a protein called alpha-synuclein was building up, which is similar to what's seen in Parkinson's disease, and cellular recycling centers known as lysosomes were not functioning properly. This lysosomal dysfunction may be causing alpha-synuclein accumulation.

"What we are seeing using this new model are the very first signs of young-onset Parkinson's," said Svendsen. "It appears that dopamine neurons in these individuals may continue to mishandle alpha-synuclein over a period of 20 or 30 years, causing Parkinson's symptoms to emerge."

The researchers also tested drugs using the cells they engineered to see if any could stop or reverse the dysfunctions. One drug called PEP005 that is already used to treat skin precancers was able to lower the high alpha-synuclein levels in the cells as well as in a mouse model.

The team wants to learn more about how this drug might be used to prevent or treat early-onset Parkinson's disease, and whether the abnormalities they identified hold true for other types of Parkinson's.

Sources: Science Daily via Cedars-Sinai Medical Center, Nature Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 15, 2020
Genetics & Genomics
MAR 15, 2020
Insight Into Neuronal Growth and Memory Formation
Now scientists have learned more about the transport of mRNA in neurons, and the storage and formation of memories.
APR 02, 2020
Cancer
APR 02, 2020
Diagnosing Cancer: SMOC2 and Thyroid Cancer
  Thyroid cancer is the most common of the endocrine cancers, with papillary thyroid carcinomas (PTCs) being the mo ...
APR 03, 2020
Genetics & Genomics
APR 03, 2020
Physical Forces Can Change How Genes Are Expressed
Less than a millisecond after a cell is stretched out, genes are activated, which will result in the production of prote ...
APR 27, 2020
Cell & Molecular Biology
APR 27, 2020
Cold Foods Don't Taste as Good, Even to Flies
The deliciousness of a food appeal is about a lot more than just taste.
MAY 24, 2020
Cell & Molecular Biology
MAY 24, 2020
Common Chemicals May Contribute to Obesity
Several explanations have been proposed to answer the question of why obesity has been on the rise for many years in the ...
MAY 26, 2020
Immunology
MAY 26, 2020
The Hunt for Rare Immune Cells, to InfinityFlow and Beyond
The immune landscape is staggeringly complex, with a myriad of genetically and functionally distinct immune cell subpopu ...
Loading Comments...